Amgen Inc.
TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR

Last updated:

Abstract:

Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula (I) and Formula (II) have the following structures: (I); (II). Intermediates (V) are also claimed. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

3 Nov 2017

Issue date:

12 Sep 2019